Pharmacy & Formulary Resources

  • CHANTIX
    Recalled Medication: Chantix, Varenicline tablets
    Manufacturer: Pfizer
    Recall Date: 09/16/2021
    Reason: N-nitroso-varenicline above acceptable daily intake level
    FDA Notice
  • CHANTIX® (Varenicline) Tablets
    Recalled Medication: Chantix
    Manufacturer: Pfizer
    Recall Date: 07/16/2021
    Reason: N-Nitroso Varenicline content above ADI level
    FDA Notice
  • Recalled Medication: Paroex Chlorhexidine Gluconate Oral Rinse, 4 oz and 16 oz
    Manufacturer: Sunstar Americas, Inc.
    Recall Date: 12/28/2020
    Reason: Potential contamination with Burkholderia lata
    FDA Notice
  • Recalled Medication: Metformin Hydrochloride Extended-Release Tablets, USP 500mg & 750mg
    Manufacturer: Marksans Pharma Limited
    Recall Date: 10/05/2020
    Reason: Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity
    FDA Notice
  • Recalled Medication: Albuterol Sulfate Inhalation Aerosol
    Manufacturer: Catalent Pharma Solutions for Perrigo Pharmaceutical Company
    Recall Date: 09/21/2020
    Reason: Due to possible clogging of the inhaler resulting in patients not receiving enough or any medicine.
    FDA Notice
  • DDAVP® Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, STIMATE® Nasal Spray 1.5 mg/mL
    Manufacturer: Ferring Pharmaceuticals US
    Recall Date: 08/05/2020
    Reason: These products are being recalled due to superpotency or amounts of desmopressin higher than specified.
    FDA Notice
  • Metformin Hydrochloride Extended-Release Tablets, 500mg and 1000mg
    Manufacturer: Lupin Pharmaceuticals, Inc.
    Recall Date: 07/08/2020
    Reason: Due to the detection of N-Nitrosodimethylamine (NDMA).
    FDA Notice
  • Metformin Hydrochloride Extended-Release Tablets USP, 750mg
    Manufacturer: Granules Pharmaceuticals, Inc.
    Recall Date: 07/03/2020
    Reason: Due to the detection of N-Nitrosodimethylamine (NDMA).
    FDA Notice
  • Coumadin
    Manufacturer: Bristol Myers Squibb
    Discontinued Date: 06/01/2020
    Reason: Unexpected manufacturing issue.
    Official Notice
  • Metformin Hydrochloride Extended-Release Tablets, USP 500mg and 750mg
    Manufacturer: Amneal Pharmaceuticals LLC
    Recall Date: 05/29/2020
    Reason: Due to detection of N-Nitrosodimethylamine (NDMA).
    FDA Notice
  • Metformin Hydrochloride Extended-Release Tablets, USP 500mg
    Manufacturer: Apotex Corp.
    Recall Date: 05/27/2020
    Reason: Due to detection of N-Nitrosodimethylamine (NDMA).
    FDA Notice
  • All Ranitidine Products (Zantac)
    Manufacturer: All
    Recall Date: 04/01/2020
    Reason: Ongoing investigation of a contaminant known as N-Nitrosodimethylamine (NDMA) which is a probable human carcinogen (a substance that could cause cancer).
    FDA Notice
  • Ranitidine Tablets, 150 mg and 300 mg, and Ranitidine Syrup (Ranitidine Oral Solution, USP), 15 mg/mL
    Manufacturer: Amneal Pharmaceuticals, LLC
    Recall Date: 11/08/2019
    Reason: Due to potential N-Nitrosodimethylamine (NDMA) amounts being above levels established by the FDA.
    FDA Notice
  • Ranitidine Tablets 150mg, Ranitidine Capsules 150 mg, Ranitidine Capsules 300 mg and Ranitidine Syrup 15 mg/mLRanitidine Tablets, Capsules, and Syrup
    Manufacturer: Aurobindo Pharma USA, Inc.
    Recall Date: 11/06/2019
    Reason: Due to the detection of Nitrosodimethylamine (NDMA) impurity.
    FDA Notice
  • Ranitidine Syrup (Oral Solution, USP), 15 mg/mL
    Manufacturer: Lannett Company, Inc.
    Recall Date: 10/25/2019
    Reason: Due to levels of N-Nitrosodimethylamine (NDMA) being above the levels recently established by the FDA.
    FDA Notice
  • Ranitidine Tablets & Capsules
    Manufacturer: Dr. Reddy’s Laboratories Ltd.
    Recall Date: 10/23/2019
    Reason: Contamination with N-Nitrosodimethylamine (NDMA) above the levels established by the FDA.
    FDA Notice
  • Losartan Potassium 50mg and Losartan Potassium/Hydrochlorothiazide combination Tablets 50mg/12.5mg, 100mg/12.5mg and 100mg/25mg
    Recall Date: 06/26/2019
    Manufacturer: Macleods Pharmaceuticals, Ltd.
    Reason: Detection of trace amounts of N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) above the interim acceptable daily intake levels released by the FDA.
    FDA Notice 
  • Losartan Potassium/Hydrochlorothiazide Combination Tablets 100mg/25mg
    Recall Date: 02/22/2019
    Manufacturer: Macleods Pharmaceuticals, Ltd.
    Reason: Detection of trace amounts of an unexpected impurity (NDEA) above the interim acceptable daily intake levels released by the FDA.
    FDA Notice 
  • Losartan Potassium Tablets, USP and Losartan Potassium and Hydrochlorothiazide Tablets, USP
    Recall Date: 01/22/19
    Manufacturer: Torrent Pharmaceuticals Limited
    Reason: Detection of trace amounts of an N-nitrosodiethylamine (NDEA) above the acceptable daily intake levels released by the FDA.
    FDA Notice 
  • Irbesartan and Irbesartan HCTZ Tablets
    Recall Date: 01/18/2019
    Manufacturer: Prinston Pharmaceutical Inc. dba Solco Healthcare LLC
    Reason: Detection of trace amount of N-nitrosodiethylamine (NDEA) above the acceptable daily intake levels released by the FDA.
    FDA Notice
  • Valsartan and Valsartan-HCTZ Tablets, USP
    Recall Date: 07/18/2018
    Manufacturers: Prinston Pharmaceuticals, and TEVA Pharmaceuticals.
    Reason: It has been found that the recalled products for impurity detected. This may cause unexpected health risks.
    FDA Notice – Prinston Pharmaceuticals
    FDA Notice – TEVA Pharmaceuticals

Safety Resources

We have gathered information from press releases and other public notices about certain recalls of Food and Drug Administration (FDA)-regulated products to share with you.

Medication Safety Bulletins

If your patient is taking any of the products below:

  • Please have them consider changing to a different medication for their condition.
  • Remind them to return the recalled medication to their pharmacy.

Below are recent nationwide medication recalls and notices: